Legend Biotech Corporation American Depositary Shares
Market Cap
6.7B
Short interest (May 15)
7.8%
Net Short (Jun 03 ): -0.1%
Borrow Fee
0.25%
↓ 12.8%
Available Shares
1M
↓ 18.6%
Price Chart
Company Overview
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.